Anesthesiological approach to a case with FAHR syndrome
Sir, Fahr syndrome, defi ned by German neurologist Karl Theodor Fahr in 1930, includes neurologic, psychiatric, and cognitive disorders of unknown etiology, and is characterized by symmetric calcifi cations in the basal ganglia and cerebellar dentate nucleus, in individuals aged 5-65 years. [1] [2] [3] [4] A 58-year-old male patient, scheduled for inguinal hernia repair, had extrapyramidal movement disorders, speech-behavior disorder, urinary incontinence, a serum Ca level of 5.8 mg/dL, and diff use calcifi cations in the cerebellum, basal ganglia, periventricular areas, and the occipital lobe gyri. Peripheral oxygen saturation, electrocardiography, and non-invasive blood pressure were monitored. Following anesthetization with 1 mg/kg⁻ 1 lidocaine, 50 μg fentanil, 2 mg/kg⁻ 1 propofol, and 0.6 mg/kg -1 rocuronium, the patient was ventilated with 100% O 2 and intubated orotracheally. Anesthesia continued with 50% O 2 -50% N 2 O in 2% sevofl urane. Arterial catheterization monitored ionized calcium levels and blood pressure invasively. During the operation, 10% calcium gluconate (20 mL) was administered by titration. Four minutes from the cessation of anesthetic inhalers, the patient opened his eyes. Muscle relaxant antagonization was not required and the patient was extubated.
